Frequencies for first 10,000 rows of indi_pt variable in indi2009q1 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 1 0.01 0.01 ABDOMINAL DISTENSION | 1 0.01 0.02 ABDOMINAL PAIN | 7 0.07 0.09 ABDOMINAL PAIN UPPER | 4 0.04 0.13 ABDOMINAL RIGIDITY | 1 0.01 0.14 ABSCESS BACTERIAL | 2 0.02 0.16 ACARODERMATITIS | 2 0.02 0.18 ACCIDENT AT WORK | 1 0.01 0.19 ACCIDENTAL DRUG INTAKE BY CHILD | 6 0.06 0.25 ACCIDENTAL EXPOSURE | 1 0.01 0.26 ACCIDENTAL OVERDOSE | 2 0.02 0.28 ACINETOBACTER INFECTION | 1 0.01 0.29 ACNE | 20 0.20 0.49 ACQUIRED HAEMOPHILIA | 2 0.02 0.51 ACQUIRED IMMUNODEFICIENCY SYNDROME | 10 0.10 0.61 ACROMEGALY | 2 0.02 0.63 ACUTE CORONARY SYNDROME | 10 0.10 0.73 ACUTE GRAFT VERSUS HOST DISEASE | 1 0.01 0.74 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 1 0.01 0.75 ACUTE LEUKAEMIA | 3 0.03 0.78 ACUTE LYMPHOCYTIC LEUKAEMIA | 29 0.29 1.07 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT | 8 0.08 1.15 ACUTE MYELOID LEUKAEMIA | 17 0.17 1.32 ACUTE MYELOID LEUKAEMIA RECURRENT | 2 0.02 1.34 ACUTE MYOCARDIAL INFARCTION | 1 0.01 1.35 ACUTE SINUSITIS | 1 0.01 1.36 ADENOID CYSTIC CARCINOMA | 2 0.02 1.38 ADENOMATOUS POLYPOSIS COLI | 8 0.08 1.46 ADJUSTMENT DISORDER | 1 0.01 1.47 ADJUSTMENT DISORDER WITH DEPRESSED MOOD | 1 0.01 1.48 ADVERSE DRUG REACTION | 2 0.02 1.50 AFFECT LABILITY | 1 0.01 1.51 AFFECTIVE DISORDER | 6 0.06 1.57 AGGRESSION | 1 0.01 1.58 AGITATION | 6 0.06 1.64 ALCOHOL ABUSE | 1 0.01 1.65 ALCOHOLISM | 3 0.03 1.68 ALLERGIC COUGH | 1 0.01 1.69 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 4 0.04 1.73 ALOPECIA | 3 0.03 1.76 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 1 0.01 1.77 ALPHA-1 ANTI-TRYPSIN DEFICIENCY | 1 0.01 1.78 AMYLOIDOSIS | 12 0.12 1.90 ANAEMIA | 24 0.24 2.14 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 2.15 ANAEMIA OF MALIGNANT DISEASE | 4 0.04 2.19 ANAESTHESIA | 8 0.08 2.27 ANALGESIA | 21 0.21 2.48 ANALGESIC THERAPY | 2 0.02 2.50 ANAPHYLACTIC REACTION | 2 0.02 2.52 ANAPLASTIC ASTROCYTOMA | 5 0.05 2.57 ANDROGENETIC ALOPECIA | 2 0.02 2.59 ANGER | 3 0.03 2.62 ANGINA PECTORIS | 17 0.17 2.79 ANGIOGRAM | 10 0.10 2.89 ANGIOPLASTY | 1 0.01 2.90 ANHEDONIA | 2 0.02 2.92 ANKYLOSING SPONDYLITIS | 19 0.19 3.11 ANOGENITAL WARTS | 1 0.01 3.12 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY .. | 10 0.10 3.22 ANTIBIOTIC PROPHYLAXIS | 4 0.04 3.26 ANTIBIOTIC THERAPY | 1 0.01 3.27 ANTICOAGULANT THERAPY | 9 0.09 3.36 ANTIDEPRESSANT THERAPY | 2 0.02 3.38 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.39 ANTIFUNGAL PROPHYLAXIS | 6 0.06 3.45 ANTIINFLAMMATORY THERAPY | 2 0.02 3.47 ANTIPLATELET THERAPY | 9 0.09 3.56 ANTIRETROVIRAL THERAPY | 13 0.13 3.69 ANTISOCIAL BEHAVIOUR | 1 0.01 3.70 ANTIVIRAL PROPHYLAXIS | 5 0.05 3.75 ANTIVIRAL TREATMENT | 2 0.02 3.77 ANXIETY | 89 0.89 4.66 ANXIETY DISORDER | 1 0.01 4.67 AORTIC ANEURYSM | 1 0.01 4.68 APLASTIC ANAEMIA | 5 0.05 4.73 APPETITE DISORDER | 1 0.01 4.74 ARNOLD-CHIARI MALFORMATION | 2 0.02 4.76 ARRHYTHMIA | 12 0.12 4.88 ARRHYTHMIA PROPHYLAXIS | 1 0.01 4.89 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 4.90 ARTERIOSCLEROSIS OBLITERANS | 1 0.01 4.91 ARTHRALGIA | 54 0.54 5.45 ARTHRITIS | 44 0.44 5.89 ARTIFICIAL INSEMINATION BY PARTNER | 3 0.03 5.92 ASCITES | 4 0.04 5.96 ASPERGILLOSIS | 4 0.04 6.00 ASPIRATION BIOPSY | 1 0.01 6.01 ASTHENIA | 1 0.01 6.02 ASTHMA | 133 1.33 7.35 ASTHMA EXERCISE INDUCED | 1 0.01 7.36 ASTROCYTOMA MALIGNANT | 1 0.01 7.37 ATRIAL FIBRILLATION | 43 0.43 7.80 ATRIAL FLUTTER | 9 0.09 7.89 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 14 0.14 8.03 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 8.04 AUTISM | 2 0.02 8.06 AUTOIMMUNE HEPATITIS | 3 0.03 8.09 AUTOIMMUNE THYROIDITIS | 2 0.02 8.11 AUTOLOGOUS BONE MARROW TRANSPLANTATIO.. | 1 0.01 8.12 B PRECURSOR TYPE ACUTE LEUKAEMIA | 5 0.05 8.17 B-CELL LYMPHOMA | 4 0.04 8.21 B-CELL SMALL LYMPHOCYTIC LYMPHOMA REC.. | 1 0.01 8.22 BACK DISORDER | 1 0.01 8.23 BACK INJURY | 2 0.02 8.25 BACK PAIN | 91 0.91 9.16 BACTERAEMIA | 1 0.01 9.17 BACTERIAL INFECTION | 2 0.02 9.19 BACTERIAL SEPSIS | 1 0.01 9.20 BASEDOW'S DISEASE | 1 0.01 9.21 BENIGN PROSTATIC HYPERPLASIA | 32 0.32 9.53 BILE DUCT CANCER RECURRENT | 2 0.02 9.55 BILE DUCT CANCER STAGE I | 1 0.01 9.56 BILIARY TRACT DISORDER | 1 0.01 9.57 BIOPSY BREAST | 2 0.02 9.59 BIPOLAR DISORDER | 37 0.37 9.96 BIPOLAR I DISORDER | 9 0.09 10.05 BIPOLAR II DISORDER | 1 0.01 10.06 BLADDER CANCER | 7 0.07 10.13 BLADDER DISORDER | 4 0.04 10.17 BLADDER PAIN | 1 0.01 10.18 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 2 0.02 10.20 BLEPHARITIS | 1 0.01 10.21 BLISTER | 1 0.01 10.22 BLOOD CALCIUM | 2 0.02 10.24 BLOOD CALCIUM DECREASED | 3 0.03 10.27 BLOOD CHOLESTEROL | 17 0.17 10.44 BLOOD CHOLESTEROL INCREASED | 77 0.77 11.21 BLOOD GLUCOSE ABNORMAL | 1 0.01 11.22 BLOOD GLUCOSE INCREASED | 3 0.03 11.25 BLOOD IRON INCREASED | 1 0.01 11.26 BLOOD LACTATE DEHYDROGENASE INCREASED | 3 0.03 11.29 BLOOD PHOSPHORUS ABNORMAL | 1 0.01 11.30 BLOOD PHOSPHORUS INCREASED | 2 0.02 11.32 BLOOD PRESSURE | 23 0.23 11.55 BLOOD PRESSURE ABNORMAL | 3 0.03 11.58 BLOOD PRESSURE DECREASED | 3 0.03 11.61 BLOOD PRESSURE INCREASED | 13 0.13 11.74 BLOOD PRESSURE MANAGEMENT | 1 0.01 11.75 BLOOD TEST ABNORMAL | 1 0.01 11.76 BLOOD TESTOSTERONE INCREASED | 1 0.01 11.77 BLOOD TRIGLYCERIDES ABNORMAL | 1 0.01 11.78 BLOOD TRIGLYCERIDES INCREASED | 6 0.06 11.84 BODY HEIGHT BELOW NORMAL | 3 0.03 11.87 BODY TEMPERATURE INCREASED | 1 0.01 11.88 BODY TINEA | 1 0.01 11.89 BONE DENSITY DECREASED | 4 0.04 11.93 BONE DISORDER | 1 0.01 11.94 BONE LESION | 4 0.04 11.98 BONE MARROW CONDITIONING REGIMEN | 17 0.17 12.15 BONE MARROW FAILURE | 1 0.01 12.16 BONE MARROW TRANSPLANT | 1 0.01 12.17 BONE NEOPLASM | 1 0.01 12.18 BONE PAIN | 3 0.03 12.21 BONE SCAN | 1 0.01 12.22 BORDERLINE PERSONALITY DISORDER | 3 0.03 12.25 BOWEL PREPARATION | 1 0.01 12.26 BRADYCARDIA | 2 0.02 12.28 BRAIN ABSCESS | 1 0.01 12.29 BRAIN NEOPLASM MALIGNANT | 1 0.01 12.30 BRAIN OEDEMA | 2 0.02 12.32 BREAKTHROUGH PAIN | 4 0.04 12.36 BREAST CANCER | 139 1.39 13.75 BREAST CANCER FEMALE | 2 0.02 13.77 BREAST CANCER METASTATIC | 19 0.19 13.96 BREAST CANCER RECURRENT | 3 0.03 13.99 BREAST CANCER STAGE II | 1 0.01 14.00 BREAST NEOPLASM | 1 0.01 14.01 BRONCHIAL CARCINOMA | 4 0.04 14.05 BRONCHIAL OBSTRUCTION | 1 0.01 14.06 BRONCHIECTASIS | 1 0.01 14.07 BRONCHITIS | 20 0.20 14.27 BRONCHITIS CHRONIC | 13 0.13 14.40 BRONCHOPULMONARY ASPERGILLOSIS | 5 0.05 14.45 BRONCHOPULMONARY DYSPLASIA | 1 0.01 14.46 BRONCHOSPASM | 3 0.03 14.49 BURSITIS | 1 0.01 14.50 CANCER PAIN | 16 0.16 14.66 CANDIDIASIS | 4 0.04 14.70 CARCINOID SYNDROME | 2 0.02 14.72 CARCINOID TUMOUR | 1 0.01 14.73 CARDIAC DISORDER | 40 0.40 15.13 CARDIAC FAILURE | 20 0.20 15.33 CARDIAC FAILURE CHRONIC | 11 0.11 15.44 CARDIAC FAILURE CONGESTIVE | 6 0.06 15.50 CARDIAC OPERATION | 12 0.12 15.62 CARDIAC STRESS TEST | 5 0.05 15.67 CARDIOMYOPATHY | 6 0.06 15.73 CARDIOVASCULAR DISORDER | 1 0.01 15.74 CARDIOVASCULAR EVENT PROPHYLAXIS | 8 0.08 15.82 CARDIOVASCULAR INSUFFICIENCY | 3 0.03 15.85 CARTILAGE INJURY | 1 0.01 15.86 CASTLEMAN'S DISEASE | 1 0.01 15.87 CATAPLEXY | 1 0.01 15.88 CATHETER RELATED INFECTION | 4 0.04 15.92 CATHETERISATION CARDIAC | 1 0.01 15.93 CELLULITIS | 5 0.05 15.98 CEREBRAL ARTERY EMBOLISM | 2 0.02 16.00 CEREBRAL INFARCTION | 6 0.06 16.06 CEREBRAL PALSY | 1 0.01 16.07 CEREBROVASCULAR ACCIDENT | 2 0.02 16.09 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 6 0.06 16.15 CERVICOBRACHIAL SYNDROME | 1 0.01 16.16 CERVIX CARCINOMA | 6 0.06 16.22 CHANGE OF BOWEL HABIT | 2 0.02 16.24 CHEMOTHERAPY | 11 0.11 16.35 CHEST PAIN | 7 0.07 16.42 CHONDROCALCINOSIS PYROPHOSPHATE | 1 0.01 16.43 CHOROIDAL NEOVASCULARISATION | 3 0.03 16.46 CHRONIC GRAFT VERSUS HOST DISEASE | 3 0.03 16.49 CHRONIC LYMPHOCYTIC LEUKAEMIA | 28 0.28 16.77 CHRONIC MYELOID LEUKAEMIA | 18 0.18 16.95 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 116 1.16 18.11 CLOSTRIDIAL INFECTION | 1 0.01 18.12 COAGULOPATHY | 1 0.01 18.13 COLITIS | 1 0.01 18.14 COLITIS ULCERATIVE | 13 0.13 18.27 COLLAPSE OF LUNG | 1 0.01 18.28 COLON CANCER | 36 0.36 18.64 COLON CANCER METASTATIC | 19 0.19 18.83 COLON CANCER RECURRENT | 4 0.04 18.87 COLONIC POLYP | 1 0.01 18.88 COLONOSCOPY | 8 0.08 18.96 COLORECTAL CANCER | 34 0.34 19.30 COLORECTAL CANCER METASTATIC | 14 0.14 19.44 COLORECTAL CANCER RECURRENT | 1 0.01 19.45 COMPLETED SUICIDE | 1 0.01 19.46 COMPLEX PARTIAL SEIZURES | 2 0.02 19.48 COMPLEX REGIONAL PAIN SYNDROME | 3 0.03 19.51 COMPRESSION FRACTURE | 1 0.01 19.52 COMPUTERISED TOMOGRAM | 9 0.09 19.61 COMPUTERISED TOMOGRAM ABDOMEN | 22 0.22 19.83 COMPUTERISED TOMOGRAM THORAX | 1 0.01 19.84 CONJUNCTIVITIS | 3 0.03 19.87 CONJUNCTIVITIS ALLERGIC | 1 0.01 19.88 CONNECTIVE TISSUE DISORDER | 3 0.03 19.91 CONSTIPATION | 45 0.45 20.36 CONSTIPATION PROPHYLAXIS | 1 0.01 20.37 CONTRACEPTION | 151 1.51 21.88 CONTRAST MEDIA REACTION | 1 0.01 21.89 CONVULSION | 30 0.30 22.19 CONVULSION PROPHYLAXIS | 1 0.01 22.20 CORD BLOOD TRANSPLANT THERAPY | 2 0.02 22.22 CORNEAL OEDEMA | 1 0.01 22.23 CORONARY ANGIOPLASTY | 1 0.01 22.24 CORONARY ARTERIAL STENT INSERTION | 5 0.05 22.29 CORONARY ARTERY BYPASS | 4 0.04 22.33 CORONARY ARTERY DISEASE | 7 0.07 22.40 CORONARY ARTERY OCCLUSION | 1 0.01 22.41 COUGH | 12 0.12 22.53 CROHN'S DISEASE | 44 0.44 22.97 CRYPTOCOCCOSIS | 1 0.01 22.98 CUTANEOUS LUPUS ERYTHEMATOSUS | 7 0.07 23.05 CYSTITIS | 6 0.06 23.11 CYTOGENETIC ABNORMALITY | 1 0.01 23.12 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 23.13 DEAFNESS | 1 0.01 23.14 DECUBITUS ULCER | 3 0.03 23.17 DEEP VEIN THROMBOSIS | 7 0.07 23.24 DELIRIUM | 1 0.01 23.25 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 23.26 DEMENTIA | 7 0.07 23.33 DEMENTIA ALZHEIMER'S TYPE | 12 0.12 23.45 DENTAL CARE | 3 0.03 23.48 DENTAL DISORDER PROPHYLAXIS | 1 0.01 23.49 DEPRESSION | 207 2.07 25.56 DEPRESSIVE SYMPTOM | 3 0.03 25.59 DERMATITIS | 1 0.01 25.60 DERMATITIS ACNEIFORM | 1 0.01 25.61 DERMATITIS ATOPIC | 2 0.02 25.63 DERMATITIS CONTACT | 1 0.01 25.64 DERMATOMYOSITIS | 4 0.04 25.68 DESMOID TUMOUR | 1 0.01 25.69 DEVICE RELATED INFECTION | 1 0.01 25.70 DIABETES MELLITUS | 117 1.17 26.87 DIABETES PROPHYLAXIS | 1 0.01 26.88 DIABETIC NEPHROPATHY | 1 0.01 26.89 DIABETIC NEUROPATHY | 6 0.06 26.95 DIALYSIS | 3 0.03 26.98 DIARRHOEA | 8 0.08 27.06 DIFFUSE LARGE B-CELL LYMPHOMA | 47 0.47 27.53 DISEASE RECURRENCE | 1 0.01 27.54 DISSEMINATED TUBERCULOSIS | 5 0.05 27.59 DISSOCIATION | 2 0.02 27.61 DISSOCIATIVE IDENTITY DISORDER | 1 0.01 27.62 DIURETIC THERAPY | 3 0.03 27.65 DIVERTICULITIS | 1 0.01 27.66 DIVERTICULUM | 1 0.01 27.67 DIZZINESS | 1 0.01 27.68 DRUG ABUSE | 4 0.04 27.72 DRUG DEPENDENCE | 13 0.13 27.85 DRUG ERUPTION | 2 0.02 27.87 DRUG EXPOSURE DURING PREGNANCY | 33 0.33 28.20 DRUG THERAPY | 1 0.01 28.21 DRUG TOXICITY | 1 0.01 28.22 DRUG USE FOR UNKNOWN INDICATION | 1,995 19.95 48.17 DRUG WITHDRAWAL MAINTENANCE THERAPY | 1 0.01 48.18 DRY EYE | 8 0.08 48.26 DRY MOUTH | 1 0.01 48.27 DUODENAL ULCER | 1 0.01 48.28 DUODENITIS | 1 0.01 48.29 DYSFUNCTIONAL UTERINE BLEEDING | 1 0.01 48.30 DYSKINESIA | 2 0.02 48.32 DYSLIPIDAEMIA | 8 0.08 48.40 DYSMENORRHOEA | 18 0.18 48.58 DYSPEPSIA | 23 0.23 48.81 DYSPNOEA | 38 0.38 49.19 DYSTONIA | 1 0.01 49.20 DYSURIA | 4 0.04 49.24 EAR INFECTION | 2 0.02 49.26 EAR PAIN | 1 0.01 49.27 EATING DISORDER | 2 0.02 49.29 ECZEMA | 9 0.09 49.38 ELECTROLYTE SUBSTITUTION THERAPY | 3 0.03 49.41 EMBOLISM | 1 0.01 49.42 EMBOLISM VENOUS | 2 0.02 49.44 EMOTIONAL DISORDER | 1 0.01 49.45 EMPHYSEMA | 41 0.41 49.86 ENCEPHALITIS HERPES | 1 0.01 49.87 ENDOCARDITIS | 5 0.05 49.92 ENDOMETRIAL CANCER | 2 0.02 49.94 ENDOMETRIAL DISORDER | 1 0.01 49.95 ENTERITIS INFECTIOUS | 1 0.01 49.96 ENTEROCOCCAL INFECTION | 2 0.02 49.98 ENTEROCOLITIS | 1 0.01 49.99 ENURESIS | 1 0.01 50.00 ENZYME INDUCTION | 1 0.01 50.01 EPILEPSY | 54 0.54 50.55 ERECTILE DYSFUNCTION | 22 0.22 50.77 ERUCTATION | 1 0.01 50.78 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 50.79 ESSENTIAL HYPERTENSION | 10 0.10 50.89 ESSENTIAL THROMBOCYTHAEMIA | 1 0.01 50.90 ESSENTIAL TREMOR | 1 0.01 50.91 EUPHORIC MOOD | 1 0.01 50.92 EVIDENCE BASED TREATMENT | 3 0.03 50.95 EWING'S SARCOMA | 12 0.12 51.07 EX-TOBACCO USER | 1 0.01 51.08 EXOSTOSIS | 2 0.02 51.10 EYE DISORDER | 1 0.01 51.11 EYE PAIN | 1 0.01 51.12 EYE PRURITUS | 1 0.01 51.13 FACIAL PALSY | 1 0.01 51.14 FACTOR VII DEFICIENCY | 1 0.01 51.15 FALLOPIAN TUBE CANCER | 1 0.01 51.16 FANCONI SYNDROME | 1 0.01 51.17 FATIGUE | 2 0.02 51.19 FEAR | 1 0.01 51.20 FEBRILE NEUTROPENIA | 3 0.03 51.23 FEMUR FRACTURE | 1 0.01 51.24 FIBROMYALGIA | 21 0.21 51.45 FLATULENCE | 1 0.01 51.46 FLUID RETENTION | 5 0.05 51.51 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR .. | 1 0.01 51.52 FOOD ALLERGY | 2 0.02 51.54 FOOD POISONING | 1 0.01 51.55 FRACTURE | 1 0.01 51.56 FUNGAEMIA | 1 0.01 51.57 FUNGAL INFECTION | 2 0.02 51.59 FUNGUS CULTURE POSITIVE | 2 0.02 51.61 GALLBLADDER CANCER | 1 0.01 51.62 GASTRIC BYPASS | 1 0.01 51.63 GASTRIC CANCER | 15 0.15 51.78 GASTRIC DISORDER | 12 0.12 51.90 GASTRIC INFECTION | 3 0.03 51.93 GASTRIC PH DECREASED | 2 0.02 51.95 GASTRIC ULCER | 2 0.02 51.97 GASTRITIS | 30 0.30 52.27 GASTRITIS EROSIVE | 1 0.01 52.28 GASTRITIS PROPHYLAXIS | 5 0.05 52.33 GASTRODUODENAL ULCER | 1 0.01 52.34 GASTROINTESTINAL CARCINOMA | 1 0.01 52.35 GASTROINTESTINAL DISORDER THERAPY | 5 0.05 52.40 GASTROINTESTINAL INFECTION | 1 0.01 52.41 GASTROINTESTINAL INFLAMMATION | 3 0.03 52.44 GASTROINTESTINAL MOTILITY DISORDER | 2 0.02 52.46 GASTROINTESTINAL STROMAL TUMOUR | 6 0.06 52.52 GASTROOESOPHAGEAL CANCER | 7 0.07 52.59 GASTROOESOPHAGEAL REFLUX DISEASE | 47 0.47 53.06 GAUCHER'S DISEASE | 5 0.05 53.11 GENERAL ANAESTHESIA | 1 0.01 53.12 GENERAL PHYSICAL CONDITION | 1 0.01 53.13 GENERALISED ANXIETY DISORDER | 1 0.01 53.14 GENITAL HAEMORRHAGE | 1 0.01 53.15 GENITAL HERPES | 3 0.03 53.18 GLAUCOMA | 17 0.17 53.35 GLIOBLASTOMA | 7 0.07 53.42 GLIOBLASTOMA MULTIFORME | 14 0.14 53.56 GLOMERULONEPHRITIS CHRONIC | 1 0.01 53.57 GLYCOGEN STORAGE DISEASE TYPE II | 4 0.04 53.61 GOUT | 10 0.10 53.71 GOUTY ARTHRITIS | 2 0.02 53.73 GRAFT VERSUS HOST DISEASE | 6 0.06 53.79 GRAND MAL CONVULSION | 1 0.01 53.80 GROWTH HORMONE DEFICIENCY | 3 0.03 53.83 HAEMANGIOBLASTOMA | 1 0.01 53.84 HAEMATOPOIETIC STEM CELL MOBILISATION | 1 0.01 53.85 HAEMATURIA | 1 0.01 53.86 HAEMODIALYSIS | 2 0.02 53.88 HAEMOGLOBIN DECREASED | 1 0.01 53.89 HAEMORRHAGE | 3 0.03 53.92 HAEMORRHOIDS | 2 0.02 53.94 HALLUCINATION | 5 0.05 53.99 HEAD AND NECK CANCER | 12 0.12 54.11 HEAD INJURY | 1 0.01 54.12 HEADACHE | 32 0.32 54.44 HEART RATE | 1 0.01 54.45 HEART RATE ABNORMAL | 1 0.01 54.46 HEART RATE IRREGULAR | 3 0.03 54.49 HEART TRANSPLANT | 3 0.03 54.52 HEART VALVE OPERATION | 1 0.01 54.53 HEART VALVE REPLACEMENT | 2 0.02 54.55 HELICOBACTER INFECTION | 13 0.13 54.68 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 54.70 HEPATIC CANCER METASTATIC | 1 0.01 54.71 HEPATIC FUNCTION ABNORMAL | 1 0.01 54.72 HEPATIC NEOPLASM | 2 0.02 54.74 HEPATIC NEOPLASM MALIGNANT | 38 0.38 55.12 HEPATIC NEOPLASM MALIGNANT RECURRENT | 2 0.02 55.14 HEPATITIS B | 10 0.10 55.24 HEPATITIS C | 90 0.90 56.14 HEPATITIS C RNA POSITIVE | 1 0.01 56.15 HEPATOSPLENIC T-CELL LYMPHOMA | 8 0.08 56.23 HERNIA | 2 0.02 56.25 HERPES SIMPLEX | 1 0.01 56.26 HERPES ZOSTER | 16 0.16 56.42 HIATUS HERNIA | 4 0.04 56.46 HIGH DENSITY LIPOPROTEIN | 1 0.01 56.47 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 56.48 HIV INFECTION | 97 0.97 57.45 HIV INFECTION CDC GROUP IV SUBGROUP C2 | 3 0.03 57.48 HIV INFECTION CDC GROUP IV SUBGROUP E | 6 0.06 57.54 HORMONE LEVEL ABNORMAL | 1 0.01 57.55 HORMONE REPLACEMENT THERAPY | 7 0.07 57.62 HORMONE THERAPY | 2 0.02 57.64 HUNTINGTON'S CHOREA | 1 0.01 57.65 HYPERCALCAEMIA | 1 0.01 57.66 HYPERCHOLESTEROLAEMIA | 28 0.28 57.94 HYPERGLYCAEMIA | 2 0.02 57.96 HYPERHIDROSIS | 2 0.02 57.98 HYPERLIPIDAEMIA | 33 0.33 58.31 HYPERPARATHYROIDISM | 3 0.03 58.34 HYPERPARATHYROIDISM PRIMARY | 1 0.01 58.35 HYPERPARATHYROIDISM SECONDARY | 8 0.08 58.43 HYPERPHOSPHATAEMIA | 4 0.04 58.47 HYPERPLASIA | 1 0.01 58.48 HYPERPYREXIA | 1 0.01 58.49 HYPERSENSITIVITY | 13 0.13 58.62 HYPERTENSION | 362 3.62 62.24 HYPERTENSIVE EMERGENCY | 1 0.01 62.25 HYPERTENSIVE NEPHROPATHY | 1 0.01 62.26 HYPERTHYROIDISM | 4 0.04 62.30 HYPERTONIA | 2 0.02 62.32 HYPERTONIC BLADDER | 7 0.07 62.39 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 62.40 HYPERURICAEMIA | 3 0.03 62.43 HYPOCALCAEMIA | 2 0.02 62.45 HYPOGAMMAGLOBULINAEMIA | 1 0.01 62.46 HYPOGONADISM | 4 0.04 62.50 HYPOKALAEMIA | 1 0.01 62.51 HYPOPARATHYROIDISM | 1 0.01 62.52 HYPOPHOSPHATAEMIC RICKETS | 1 0.01 62.53 HYPOPITUITARISM | 1 0.01 62.54 HYPOTENSION | 2 0.02 62.56 HYPOTHYROIDISM | 27 0.27 62.83 HYSTERECTOMY | 1 0.01 62.84 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 6 0.06 62.90 IMMUNISATION | 1 0.01 62.91 IMMUNODEFICIENCY | 1 0.01 62.92 IMMUNODEFICIENCY COMMON VARIABLE | 1 0.01 62.93 IMMUNOSUPPRESSION | 8 0.08 63.01 IMPAIRED GASTRIC EMPTYING | 1 0.01 63.02 IMPAIRED HEALING | 1 0.01 63.03 IMPETIGO | 2 0.02 63.05 IMPULSIVE BEHAVIOUR | 2 0.02 63.07 INCONTINENCE | 1 0.01 63.08 INCREASED BRONCHIAL SECRETION | 1 0.01 63.09 INDUCTION OF ANAESTHESIA | 3 0.03 63.12 INFECTION | 9 0.09 63.21 INFECTION PROPHYLAXIS | 8 0.08 63.29 INFERTILITY | 3 0.03 63.32 INFLAMMATION | 4 0.04 63.36 INFLUENZA | 10 0.10 63.46 INFLUENZA IMMUNISATION | 2 0.02 63.48 INITIAL INSOMNIA | 3 0.03 63.51 INSOMNIA | 63 0.63 64.14 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 7 0.07 64.21 INTENTIONAL DRUG MISUSE | 1 0.01 64.22 INTENTIONAL OVERDOSE | 10 0.10 64.32 INTERNATIONAL NORMALISED RATIO INCREA.. | 1 0.01 64.33 INTERSTITIAL LUNG DISEASE | 5 0.05 64.38 INTERVERTEBRAL DISC DEGENERATION | 4 0.04 64.42 INTERVERTEBRAL DISC DISORDER | 2 0.02 64.44 INTERVERTEBRAL DISC DISPLACEMENT | 1 0.01 64.45 INTERVERTEBRAL DISC OPERATION | 1 0.01 64.46 INTERVERTEBRAL DISC PROTRUSION | 7 0.07 64.53 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 64.54 INTRACRANIAL ANEURYSM | 1 0.01 64.55 INTRAOCULAR PRESSURE INCREASED | 5 0.05 64.60 INTRAVENOUS CATHETER MANAGEMENT | 1 0.01 64.61 IRON DEFICIENCY | 2 0.02 64.63 IRON DEFICIENCY ANAEMIA | 5 0.05 64.68 IRON OVERLOAD | 10 0.10 64.78 IRRITABILITY | 1 0.01 64.79 IRRITABLE BOWEL SYNDROME | 2 0.02 64.81 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 1 0.01 64.82 ISCHAEMIC STROKE | 2 0.02 64.84 JOINT SPRAIN | 2 0.02 64.86 JOINT SWELLING | 1 0.01 64.87 JUGULAR VEIN THROMBOSIS | 2 0.02 64.89 JUVENILE ARTHRITIS | 2 0.02 64.91 KAPOSI'S SARCOMA | 1 0.01 64.92 KAPOSI'S VARICELLIFORM ERUPTION | 1 0.01 64.93 KAWASAKI'S DISEASE | 5 0.05 64.98 KIDNEY TRANSPLANT REJECTION | 1 0.01 64.99 KNEE OPERATION | 1 0.01 65.00 LABOUR COMPLICATION | 1 0.01 65.01 LARGE CELL CARCINOMA OF THE RESPIRATO.. | 1 0.01 65.02 LARGE INTESTINE CARCINOMA | 9 0.09 65.11 LATENT AUTOIMMUNE DIABETES IN ADULTS | 1 0.01 65.12 LATENT TUBERCULOSIS | 1 0.01 65.13 LAXATIVE SUPPORTIVE CARE | 1 0.01 65.14 LEIOMYOSARCOMA METASTATIC | 3 0.03 65.17 LEUKAEMIA | 3 0.03 65.20 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 65.21 LIBIDO DECREASED | 1 0.01 65.22 LICE INFESTATION | 2 0.02 65.24 LIMB OPERATION | 1 0.01 65.25 LIP AND/OR ORAL CAVITY CANCER | 5 0.05 65.30 LIPODYSTROPHY ACQUIRED | 1 0.01 65.31 LIVER DISORDER | 3 0.03 65.34 LIVER TRANSPLANT | 7 0.07 65.41 LOCAL ANAESTHESIA | 2 0.02 65.43 LOCALISED INFECTION | 2 0.02 65.45 LOSS OF CONSCIOUSNESS | 2 0.02 65.47 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 65.49 LOWER RESPIRATORY TRACT INFECTION BAC.. | 2 0.02 65.51 LUMBAR RADICULOPATHY | 2 0.02 65.53 LUNG ADENOCARCINOMA | 1 0.01 65.54 LUNG ADENOCARCINOMA METASTATIC | 1 0.01 65.55 LUNG CANCER METASTATIC | 1 0.01 65.56 LUNG DISORDER | 2 0.02 65.58 LUNG INFECTION | 4 0.04 65.62 LUNG NEOPLASM MALIGNANT | 16 0.16 65.78 LUNG SQUAMOUS CELL CARCINOMA STAGE IV | 3 0.03 65.81 LUPUS NEPHRITIS | 7 0.07 65.88 LYMPHOHISTIOCYTOSIS | 2 0.02 65.90 LYMPHOMA | 11 0.11 66.01 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 66.02 MACULAR DEGENERATION | 20 0.20 66.22 MACULAR OEDEMA | 1 0.01 66.23 MAJOR DEPRESSION | 10 0.10 66.33 MALABSORPTION | 1 0.01 66.34 MALAISE | 1 0.01 66.35 MALARIA PROPHYLAXIS | 2 0.02 66.37 MALIGNANT LYMPHOID NEOPLASM | 1 0.01 66.38 MALIGNANT MELANOMA | 11 0.11 66.49 MANIA | 4 0.04 66.53 MANTLE CELL LYMPHOMA | 18 0.18 66.71 MEDICAL DIET | 5 0.05 66.76 MEDULLOBLASTOMA | 7 0.07 66.83 MEMORY IMPAIRMENT | 1 0.01 66.84 MENINGIOMA | 1 0.01 66.85 MENINGITIS BACTERIAL | 1 0.01 66.86 MENINGITIS CRYPTOCOCCAL | 3 0.03 66.89 MENISCUS LESION | 2 0.02 66.91 MENOMETRORRHAGIA | 1 0.01 66.92 MENOPAUSAL SYMPTOMS | 6 0.06 66.98 MENOPAUSE | 9 0.09 67.07 MENORRHAGIA | 3 0.03 67.10 MENSTRUAL DISORDER | 1 0.01 67.11 MENSTRUATION IRREGULAR | 2 0.02 67.13 MENTAL DISORDER | 5 0.05 67.18 MENTAL RETARDATION | 1 0.01 67.19 METABOLIC DISORDER | 2 0.02 67.21 METASTASES TO BONE | 27 0.27 67.48 METASTASES TO LUNG | 1 0.01 67.49 METASTASIS | 2 0.02 67.51 METASTATIC GASTRIC CANCER | 4 0.04 67.55 METASTATIC MALIGNANT MELANOMA | 3 0.03 67.58 METASTATIC NEOPLASM | 3 0.03 67.61 METASTATIC PAIN | 1 0.01 67.62 METASTATIC RENAL CELL CARCINOMA | 27 0.27 67.89 MICTURITION DISORDER | 4 0.04 67.93 MIGRAINE | 33 0.33 68.26 MIGRAINE PROPHYLAXIS | 4 0.04 68.30 MINERAL SUPPLEMENTATION | 6 0.06 68.36 MITRAL VALVE INCOMPETENCE | 1 0.01 68.37 MITRAL VALVE REPAIR | 1 0.01 68.38 MONOPLEGIA | 1 0.01 68.39 MOOD SWINGS | 1 0.01 68.40 MUCOPOLYSACCHARIDOSIS I | 4 0.04 68.44 MUCOPOLYSACCHARIDOSIS II | 2 0.02 68.46 MUCOPOLYSACCHARIDOSIS VI | 2 0.02 68.48 MUCOSAL INFLAMMATION | 1 0.01 68.49 MULTIPLE ALLERGIES | 11 0.11 68.60 MULTIPLE DRUG OVERDOSE INTENTIONAL | 4 0.04 68.64 MULTIPLE MYELOMA | 101 1.01 69.65 MULTIPLE SCLEROSIS | 237 2.37 72.02 MUSCLE INJURY | 1 0.01 72.03 MUSCLE RELAXANT THERAPY | 5 0.05 72.08 MUSCLE SPASMS | 14 0.14 72.22 MUSCLE SPASTICITY | 14 0.14 72.36 MUSCLE TWITCHING | 1 0.01 72.37 MUSCULAR WEAKNESS | 3 0.03 72.40 MUSCULOSKELETAL PAIN | 11 0.11 72.51 MUSCULOSKELETAL STIFFNESS | 2 0.02 72.53 MYALGIA | 10 0.10 72.63 MYASTHENIA GRAVIS | 1 0.01 72.64 MYASTHENIC SYNDROME | 1 0.01 72.65 MYCOBACTERIAL INFECTION | 10 0.10 72.75 MYCOBACTERIUM ABSCESSUS INFECTION | 6 0.06 72.81 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 16 0.16 72.97 MYELODYSPLASTIC SYNDROME | 36 0.36 73.33 MYELOFIBROSIS | 4 0.04 73.37 MYELOMA RECURRENCE | 2 0.02 73.39 MYOCARDIAL INFARCTION | 8 0.08 73.47 MYOCARDIAL ISCHAEMIA | 6 0.06 73.53 MYOCARDITIS | 1 0.01 73.54 MYOCLONUS | 1 0.01 73.55 MYOFASCIAL PAIN SYNDROME | 1 0.01 73.56 NAIL INFECTION | 1 0.01 73.57 NARCOLEPSY | 5 0.05 73.62 NASAL CONGESTION | 2 0.02 73.64 NASAL DECONGESTION THERAPY | 1 0.01 73.65 NASAL POLYPS | 1 0.01 73.66 NASAL SINUS CANCER | 1 0.01 73.67 NASOPHARYNGITIS | 25 0.25 73.92 NAUSEA | 21 0.21 74.13 NECK MASS | 1 0.01 74.14 NECK PAIN | 9 0.09 74.23 NEOPLASM | 2 0.02 74.25 NEOPLASM MALIGNANT | 8 0.08 74.33 NEOPLASM PROPHYLAXIS | 3 0.03 74.36 NEPHRECTOMY | 1 0.01 74.37 NEPHROLITHIASIS | 1 0.01 74.38 NEPHROTIC SYNDROME | 29 0.29 74.67 NERVE BLOCK | 4 0.04 74.71 NERVE INJURY | 3 0.03 74.74 NERVE ROOT LESION | 3 0.03 74.77 NERVOUS SYSTEM DISORDER | 2 0.02 74.79 NEURALGIA | 19 0.19 74.98 NEUROBLASTOMA | 3 0.03 75.01 NEURODEGENERATIVE DISORDER | 1 0.01 75.02 NEUROFIBROMA | 1 0.01 75.03 NEUROMYELITIS OPTICA | 1 0.01 75.04 NEUROMYOPATHY | 1 0.01 75.05 NEUROPATHY PERIPHERAL | 11 0.11 75.16 NEUROSYPHILIS | 1 0.01 75.17 NEUTROPENIA | 9 0.09 75.26 NICOTINE DEPENDENCE | 1 0.01 75.27 NO THERAPEUTIC RESPONSE | 1 0.01 75.28 NON-HODGKIN'S LYMPHOMA | 39 0.39 75.67 NON-SMALL CELL LUNG CANCER | 81 0.81 76.48 NON-SMALL CELL LUNG CANCER STAGE IV | 3 0.03 76.51 NUCLEAR MAGNETIC RESONANCE IMAGING | 51 0.51 77.02 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 8 0.08 77.10 NUTRITIONAL SUPPORT | 3 0.03 77.13 OBESITY | 8 0.08 77.21 OCCIPITAL NEURALGIA | 1 0.01 77.22 OCULAR HYPERTENSION | 5 0.05 77.27 OEDEMA | 6 0.06 77.33 OEDEMA PERIPHERAL | 2 0.02 77.35 OESOPHAGEAL CARCINOMA | 15 0.15 77.50 OESOPHAGEAL ULCER | 1 0.01 77.51 OESOPHAGITIS | 1 0.01 77.52 OFF LABEL USE | 1 0.01 77.53 ONYCHOMYCOSIS | 3 0.03 77.56 OPPORTUNISTIC INFECTION PROPHYLAXIS | 2 0.02 77.58 ORAL CANDIDIASIS | 1 0.01 77.59 ORAL CONTRACEPTION | 7 0.07 77.66 ORAL FUNGAL INFECTION | 1 0.01 77.67 ORAL PAIN | 1 0.01 77.68 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 1 0.01 77.69 OROPHARYNGEAL PAIN | 1 0.01 77.70 OSTEOARTHRITIS | 31 0.31 78.01 OSTEOGENESIS IMPERFECTA | 1 0.01 78.02 OSTEOMYELITIS | 8 0.08 78.10 OSTEONECROSIS | 1 0.01 78.11 OSTEOPENIA | 12 0.12 78.23 OSTEOPOROSIS | 125 1.25 79.48 OSTEOPOROSIS POSTMENOPAUSAL | 4 0.04 79.52 OSTEOPOROSIS PROPHYLAXIS | 13 0.13 79.65 OTITIS MEDIA | 4 0.04 79.69 OVARIAN CANCER | 9 0.09 79.78 OVARIAN EPITHELIAL CANCER | 9 0.09 79.87 OVARIAN OPERATION | 2 0.02 79.89 OVERDOSE | 4 0.04 79.93 OVERWEIGHT | 3 0.03 79.96 OXYGEN SATURATION DECREASED | 2 0.02 79.98 PAIN | 154 1.54 81.52 PAIN IN EXTREMITY | 15 0.15 81.67 PAIN IN JAW | 3 0.03 81.70 PAIN MANAGEMENT | 3 0.03 81.73 PALLIATIVE CARE | 1 0.01 81.74 PANCREATIC CARCINOMA | 9 0.09 81.83 PANCREATIC CARCINOMA METASTATIC | 3 0.03 81.86 PANCREATIC CARCINOMA NON-RESECTABLE | 2 0.02 81.88 PANCREATIC CARCINOMA RECURRENT | 2 0.02 81.90 PANCREATIC INSUFFICIENCY | 1 0.01 81.91 PANCREATIC NECROSIS | 1 0.01 81.92 PANCREATITIS NECROTISING | 1 0.01 81.93 PANCYTOPENIA | 1 0.01 81.94 PANIC ATTACK | 2 0.02 81.96 PANIC DISORDER | 6 0.06 82.02 PANIC DISORDER WITH AGORAPHOBIA | 1 0.01 82.03 PARAESTHESIA | 3 0.03 82.06 PARANOIA | 1 0.01 82.07 PARATHYROID DISORDER | 1 0.01 82.08 PARKINSON'S DISEASE | 31 0.31 82.39 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 1 0.01 82.40 PARTIAL SEIZURES | 2 0.02 82.42 PATELLA FRACTURE | 1 0.01 82.43 PELVIC FRACTURE | 1 0.01 82.44 PELVIC INFLAMMATORY DISEASE | 1 0.01 82.45 PELVIC PAIN | 1 0.01 82.46 PEMPHIGUS | 1 0.01 82.47 PEPTIC ULCER | 2 0.02 82.49 PERCUTANEOUS CORONARY INTERVENTION | 4 0.04 82.53 PERIARTHRITIS | 2 0.02 82.55 PERICARDITIS | 1 0.01 82.56 PERIODONTITIS | 1 0.01 82.57 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 82.58 PERIPHERAL ISCHAEMIA | 3 0.03 82.61 PERIPHERAL VASCULAR DISORDER | 1 0.01 82.62 PERITONEAL DIALYSIS | 27 0.27 82.89 PERITONEAL INFECTION | 1 0.01 82.90 PERITONITIS | 5 0.05 82.95 PERSONALITY DISORDER | 3 0.03 82.98 PEYRONIE'S DISEASE | 1 0.01 82.99 PHANTOM PAIN | 2 0.02 83.01 PHARYNGEAL CANCER STAGE UNSPECIFIED | 2 0.02 83.03 PHARYNGITIS | 2 0.02 83.05 PHARYNGITIS STREPTOCOCCAL | 1 0.01 83.06 PHOSPHORUS METABOLISM DISORDER | 2 0.02 83.08 PHYSICAL EXAMINATION | 1 0.01 83.09 PITUITARY TUMOUR | 2 0.02 83.11 PLANTAR FASCIITIS | 2 0.02 83.13 PLEURAL EFFUSION | 1 0.01 83.14 PLEURAL INFECTION | 6 0.06 83.20 PNEUMOCYSTIS JIROVECI PNEUMONIA | 6 0.06 83.26 PNEUMONIA | 37 0.37 83.63 PNEUMONIA BACTERIAL | 1 0.01 83.64 PNEUMONIA FUNGAL | 1 0.01 83.65 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 83.66 POLLAKIURIA | 4 0.04 83.70 POLYARTHRITIS | 3 0.03 83.73 POLYCYSTIC OVARIES | 1 0.01 83.74 POLYMYALGIA RHEUMATICA | 4 0.04 83.78 POLYMYOSITIS | 1 0.01 83.79 POLYNEUROPATHY | 3 0.03 83.82 POLYP | 3 0.03 83.85 POLYPOIDAL CHOROIDAL VASCULOPATHY | 1 0.01 83.86 POLYURIA | 3 0.03 83.89 POOR PERIPHERAL CIRCULATION | 1 0.01 83.90 POST GASTRIC SURGERY SYNDROME | 1 0.01 83.91 POST HERPETIC NEURALGIA | 5 0.05 83.96 POST POLIO SYNDROME | 1 0.01 83.97 POST-TRAUMATIC EPILEPSY | 1 0.01 83.98 POST-TRAUMATIC STRESS DISORDER | 3 0.03 84.01 POSTMENOPAUSE | 1 0.01 84.02 POSTNASAL DRIP | 1 0.01 84.03 POSTOPERATIVE WOUND INFECTION | 2 0.02 84.05 POSTPARTUM DEPRESSION | 1 0.01 84.06 POSTPARTUM HAEMORRHAGE | 3 0.03 84.09 POSTURAL ORTHOSTATIC TACHYCARDIA SYND.. | 1 0.01 84.10 PREMEDICATION | 49 0.49 84.59 PREMENSTRUAL SYNDROME | 3 0.03 84.62 PREOPERATIVE CARE | 1 0.01 84.63 PRIMARY HYPOTHYROIDISM | 2 0.02 84.65 PROCEDURAL PAIN | 8 0.08 84.73 PRODUCTIVE COUGH | 9 0.09 84.82 PROGRESSIVE RELAPSING MULTIPLE SCLERO.. | 1 0.01 84.83 PROGRESSIVE SUPRANUCLEAR PALSY | 2 0.02 84.85 PROPHYLAXIS | 86 0.86 85.71 PROPHYLAXIS AGAINST DIARRHOEA | 2 0.02 85.73 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 7 0.07 85.80 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 13 0.13 85.93 PROPHYLAXIS AGAINST HIV INFECTION | 3 0.03 85.96 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 3 0.03 85.99 PROPHYLAXIS OF NAUSEA AND VOMITING | 8 0.08 86.07 PROPHYLAXIS URINARY TRACT INFECTION | 1 0.01 86.08 PROSTATE CANCER | 29 0.29 86.37 PROSTATE CANCER METASTATIC | 3 0.03 86.40 PROSTATE CANCER STAGE II | 8 0.08 86.48 PROSTATE CANCER STAGE III | 2 0.02 86.50 PROSTATE CANCER STAGE IV | 3 0.03 86.53 PROSTATE INFECTION | 1 0.01 86.54 PROSTATIC DISORDER | 3 0.03 86.57 PROSTATISM | 1 0.01 86.58 PROSTATITIS | 3 0.03 86.61 PROSTATOMEGALY | 4 0.04 86.65 PRURITUS | 4 0.04 86.69 PSEUDOCYST | 1 0.01 86.70 PSEUDOMEMBRANOUS COLITIS | 1 0.01 86.71 PSEUDOMONAS INFECTION | 5 0.05 86.76 PSORIASIS | 23 0.23 86.99 PSORIATIC ARTHROPATHY | 20 0.20 87.19 PSYCHIATRIC SYMPTOM | 1 0.01 87.20 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 87.21 PSYCHOTIC DISORDER | 15 0.15 87.36 PULMONARY ARTERIAL HYPERTENSION | 20 0.20 87.56 PULMONARY EMBOLISM | 6 0.06 87.62 PULMONARY HYPERTENSION | 11 0.11 87.73 PULMONARY VASCULAR DISORDER | 1 0.01 87.74 PULMONARY VASCULITIS | 3 0.03 87.77 PUSTULAR PSORIASIS | 3 0.03 87.80 PYELONEPHRITIS | 1 0.01 87.81 PYELONEPHRITIS ACUTE | 3 0.03 87.84 PYREXIA | 12 0.12 87.96 RADICULAR PAIN | 1 0.01 87.97 RASH | 8 0.08 88.05 RECTAL CANCER | 2 0.02 88.07 RECTAL CANCER METASTATIC | 2 0.02 88.09 RECTAL HAEMORRHAGE | 1 0.01 88.10 RECURRENT CANCER | 1 0.01 88.11 REFLUX GASTRITIS | 1 0.01 88.12 REFLUX OESOPHAGITIS | 2 0.02 88.14 REITER'S SYNDROME | 1 0.01 88.15 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 11 0.11 88.26 RELAXATION THERAPY | 1 0.01 88.27 RENAL CANCER | 6 0.06 88.33 RENAL CANCER METASTATIC | 1 0.01 88.34 RENAL CELL CARCINOMA | 39 0.39 88.73 RENAL CELL CARCINOMA STAGE III | 1 0.01 88.74 RENAL CELL CARCINOMA STAGE IV | 11 0.11 88.85 RENAL DISORDER | 1 0.01 88.86 RENAL FAILURE | 8 0.08 88.94 RENAL FAILURE CHRONIC | 25 0.25 89.19 RENAL TRANSPLANT | 31 0.31 89.50 RESORPTION BONE INCREASED | 4 0.04 89.54 RESPIRATORY DISORDER NEONATAL | 12 0.12 89.66 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 89.67 RESPIRATORY TRACT INFECTION | 6 0.06 89.73 RESTLESS LEGS SYNDROME | 15 0.15 89.88 RESTLESSNESS | 2 0.02 89.90 RETROPERITONEAL FIBROSIS | 3 0.03 89.93 RHABDOMYOSARCOMA | 15 0.15 90.08 RHEUMATOID ARTHRITIS | 221 2.21 92.29 RHEUMATOID LUNG | 2 0.02 92.31 RHINITIS | 1 0.01 92.32 RHINITIS ALLERGIC | 1 0.01 92.33 RHINITIS SEASONAL | 3 0.03 92.36 RIB FRACTURE | 1 0.01 92.37 RIFT VALLEY FEVER | 1 0.01 92.38 ROAD TRAFFIC ACCIDENT | 2 0.02 92.40 ROTATOR CUFF SYNDROME | 1 0.01 92.41 ROUTINE HEALTH MAINTENANCE | 2 0.02 92.43 SALIVARY HYPERSECRETION | 1 0.01 92.44 SARCOIDOSIS | 3 0.03 92.47 SCAN | 12 0.12 92.59 SCAN MYOCARDIAL PERFUSION | 9 0.09 92.68 SCAN PARATHYROID | 2 0.02 92.70 SCAR | 1 0.01 92.71 SCHIZOAFFECTIVE DISORDER | 11 0.11 92.82 SCHIZOPHRENIA | 75 0.75 93.57 SCHIZOPHRENIA, PARANOID TYPE | 2 0.02 93.59 SCHIZOPHRENIA, RESIDUAL TYPE | 2 0.02 93.61 SCIATICA | 8 0.08 93.69 SEASONAL AFFECTIVE DISORDER | 1 0.01 93.70 SEASONAL ALLERGY | 2 0.02 93.72 SEBORRHOEIC DERMATITIS | 4 0.04 93.76 SECONDARY HYPERTHYROIDISM | 1 0.01 93.77 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 2 0.02 93.79 SECRETION DISCHARGE | 1 0.01 93.80 SEDATION | 6 0.06 93.86 SEDATIVE THERAPY | 5 0.05 93.91 SEIZURE ANOXIC | 1 0.01 93.92 SENSORY LOSS | 2 0.02 93.94 SEPSIS | 8 0.08 94.02 SEPTIC SHOCK | 6 0.06 94.08 SHOULDER OPERATION | 1 0.01 94.09 SICKLE CELL ANAEMIA | 1 0.01 94.10 SILICOSIS | 1 0.01 94.11 SINUS DISORDER | 3 0.03 94.14 SINUS OPERATION | 1 0.01 94.15 SINUSITIS | 30 0.30 94.45 SJOGREN'S SYNDROME | 2 0.02 94.47 SKIN CANDIDA | 1 0.01 94.48 SKIN INFECTION | 4 0.04 94.52 SKIN LACERATION | 1 0.01 94.53 SKIN PAPILLOMA | 1 0.01 94.54 SKIN WRINKLING | 2 0.02 94.56 SLEEP DISORDER | 26 0.26 94.82 SMALL INTESTINE CARCINOMA | 4 0.04 94.86 SMOKING CESSATION THERAPY | 75 0.75 95.61 SOCIAL PHOBIA | 5 0.05 95.66 SOFT TISSUE INJURY | 1 0.01 95.67 SOMATOFORM DISORDER | 1 0.01 95.68 SOMNOLENCE | 3 0.03 95.71 SPINAL COLUMN STENOSIS | 2 0.02 95.73 SPINAL CORD COMPRESSION | 2 0.02 95.75 SPINAL CORD INJURY | 1 0.01 95.76 SPINAL DISORDER | 3 0.03 95.79 SPINAL OSTEOARTHRITIS | 1 0.01 95.80 SPORTS INJURY | 1 0.01 95.81 SPUTUM ABNORMAL | 1 0.01 95.82 SPUTUM DISCOLOURED | 1 0.01 95.83 SQUAMOUS CELL CARCINOMA | 3 0.03 95.86 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 95.87 STAPHYLOCOCCAL INFECTION | 7 0.07 95.94 STATUS EPILEPTICUS | 4 0.04 95.98 STEM CELL TRANSPLANT | 6 0.06 96.04 STENT PLACEMENT | 7 0.07 96.11 STOMATITIS | 3 0.03 96.14 STRESS | 1 0.01 96.15 SUBCUTANEOUS ABSCESS | 1 0.01 96.16 SUICIDAL BEHAVIOUR | 1 0.01 96.17 SUICIDE ATTEMPT | 3 0.03 96.20 SUPPLEMENTATION THERAPY | 7 0.07 96.27 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 96.28 SURGERY | 2 0.02 96.30 SWELLING | 1 0.01 96.31 SYSTEMIC CANDIDA | 4 0.04 96.35 SYSTEMIC LUPUS ERYTHEMATOSUS | 13 0.13 96.48 T-CELL DEPLETION | 1 0.01 96.49 T-CELL TYPE ACUTE LEUKAEMIA | 12 0.12 96.61 TACHYCARDIA | 3 0.03 96.64 TACHYCARDIA PAROXYSMAL | 1 0.01 96.65 TEMPORAL ARTERITIS | 2 0.02 96.67 TENDONITIS | 2 0.02 96.69 TENSION HEADACHE | 2 0.02 96.71 THALASSAEMIA BETA | 1 0.01 96.72 THERMAL BURN | 2 0.02 96.74 THROMBOCYTHAEMIA | 1 0.01 96.75 THROMBOCYTOPENIA | 2 0.02 96.77 THROMBOPHLEBITIS | 1 0.01 96.78 THROMBOPHLEBITIS MIGRANS | 1 0.01 96.79 THROMBOSIS | 7 0.07 96.86 THROMBOSIS PROPHYLAXIS | 26 0.26 97.12 THROMBOTIC CEREBRAL INFARCTION | 1 0.01 97.13 THYMUS DISORDER | 1 0.01 97.14 THYROID CANCER | 3 0.03 97.17 THYROID DISORDER | 11 0.11 97.28 THYROIDECTOMY | 1 0.01 97.29 TINEA PEDIS | 3 0.03 97.32 TOBACCO USER | 1 0.01 97.33 TOOTH ABSCESS | 1 0.01 97.34 TOOTH DISORDER | 1 0.01 97.35 TOOTH INFECTION | 1 0.01 97.36 TOOTHACHE | 4 0.04 97.40 TOURETTE'S DISORDER | 2 0.02 97.42 TOXOPLASMOSIS PROPHYLAXIS | 1 0.01 97.43 TRANSIENT ISCHAEMIC ATTACK | 7 0.07 97.50 TRANSITIONAL CELL CARCINOMA | 1 0.01 97.51 TRANSPLANT | 1 0.01 97.52 TRANSPLANT REJECTION | 2 0.02 97.54 TRANSURETHRAL RESECTION SYNDROME | 1 0.01 97.55 TRAUMATIC HAEMORRHAGE | 1 0.01 97.56 TREMOR | 4 0.04 97.60 TUBERCULOSIS | 23 0.23 97.83 TUMOUR PAIN | 1 0.01 97.84 TURNER'S SYNDROME | 2 0.02 97.86 TYPE 1 DIABETES MELLITUS | 11 0.11 97.97 TYPE 2 DIABETES MELLITUS | 89 0.89 98.86 ULCER | 4 0.04 98.90 UNEVALUABLE EVENT | 10 0.10 99.00 UPPER RESPIRATORY TRACT INFECTION | 4 0.04 99.04 URINARY INCONTINENCE | 6 0.06 99.10 URINARY RETENTION | 1 0.01 99.11 URINARY TRACT INFECTION | 17 0.17 99.28 UROLOGICAL EXAMINATION ABNORMAL | 1 0.01 99.29 URTICARIA | 3 0.03 99.32 UTERINE CANCER | 1 0.01 99.33 UTERINE LEIOMYOMA | 1 0.01 99.34 UVEITIS | 1 0.01 99.35 VACCINIA | 1 0.01 99.36 VAGINAL HAEMORRHAGE | 1 0.01 99.37 VAGINAL INFECTION | 1 0.01 99.38 VAGINITIS BACTERIAL | 1 0.01 99.39 VASCULITIS | 2 0.02 99.41 VASCULITIS CEREBRAL | 3 0.03 99.44 VENOGRAM | 1 0.01 99.45 VENTRICULAR HYPERTROPHY | 1 0.01 99.46 VENTRICULAR TACHYCARDIA | 2 0.02 99.48 VERTIGO | 1 0.01 99.49 VIRAL INFECTION | 1 0.01 99.50 VITAMIN B6 DEFICIENCY | 2 0.02 99.52 VITAMIN D | 1 0.01 99.53 VITAMIN D DEFICIENCY | 2 0.02 99.55 VITAMIN SUPPLEMENTATION | 9 0.09 99.64 VOMITING | 4 0.04 99.68 VULVOVAGINAL CANDIDIASIS | 1 0.01 99.69 VULVOVAGINAL MYCOTIC INFECTION | 2 0.02 99.71 WALDENSTROM'S MACROGLOBULINAEMIA | 2 0.02 99.73 WALKING DISABILITY | 1 0.01 99.74 WEGENER'S GRANULOMATOSIS | 2 0.02 99.76 WEIGHT CONTROL | 4 0.04 99.80 WEIGHT DECREASED | 2 0.02 99.82 WEIGHT LOSS DIET | 2 0.02 99.84 WHEEZING | 9 0.09 99.93 WOUND INFECTION | 2 0.02 99.95 WRONG DRUG ADMINISTERED | 1 0.01 99.96 ZYGOMYCOSIS | 4 0.04 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015